Cokey Nguyen

Cokey Nguyen serves as President and CEO at Atara Biotherapeutics. Atara Biotherapeutics operates in the research sector with approximately 190.0 employees. The company is headquartered in Thousand Oaks, California. Atara Biotherapeutics generates annual revenue of 128940000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Mimecast Microsoft Office 365 Drupal WP Engine Atlassian Cloud OneTrust Salesforce IoT Remote

biotechnology immunotherapy cell therapy gene therapy regenerative medicine tcells cytotoxic t lymphocytes ctls allogeneic off the shelf cancer oncology immunooncology hematology immunology autoimmune diseases multiple sclerosis ms epsteinbarr virus ebv posttransplant lymphoproliferative disorder ptld nasopharyngeal carcinoma cytomegalovirus cmv oncoviruses bone marrow transplant stem cell transplant solid organ transplant lymphoma secondary lymphoma secondary malignancy lymphoproliferative disorders ebv lymphoma atara bio atara atra car t solid tumors allogeneic cd19 car t allogeneic ebv car tcell platform allogeneic car tcell therapies progressive multiple sclerosis biotechnology: biological products (no diagnostic substances) health care biotechnology research t-cell immunotherapy allogeneic therapies pipeline development clinical studies cancer treatment autoimmune disease viral disease ebv-targeted therapies tabelecleucel ptld treatment off-the-shelf therapies cell-based innovation robust manufacturing transformative therapies rapid delivery investigational therapies safety evaluation efficacy studies expanded access programs healthcare providers investor relations biopharmaceutical development genetically engineered t-cells immuno-oncology hematological malignancies b-cell autoimmune diseases partnerships with academic institutions gene editing alternatives next-generation biotechnology scientific collaborations disease-causing cells immune system harnessing therapeutic innovation chronic disease management adaptive pathways strategic governance portfolio of therapies biotech vision transplant lymphoproliferative disease clinical efficacy patient stories healthcare advancements regulatory approval innovative technologies immune response modulation biotech market dynamics pharmaceutical partnerships allogeneic t-cell immunotherapy epstein-barr virus ebv+ ptld car t-cell therapy innovative therapies patient-centric scalable manufacturing b-cell malignancies clinical trials unmet medical needs research collaborations therapeutic focus cell therapy manufacturing rapid treatment options biopharmaceutical partnerships competitive landscape patient access advanced therapies strategic objectives core values integrity innovation collaboration hospital & health care health wellness & fitness

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Cokey Nguyen?

Cokey Nguyen's verified email address is available on MessageCEO. They currently work at Atara Biotherapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Cokey Nguyen lead?

Cokey Nguyen is President and CEO at Atara Biotherapeutics, a company in the research sector with 190.0 employees. The company is based in Thousand Oaks, California.

What industry is Cokey Nguyen in?

Cokey Nguyen works in the research industry as President and CEO at Atara Biotherapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Cokey Nguyen's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Cokey Nguyen's profile is kept up-to-date with the latest available information.

Last updated: April 11, 2026